FOR AUTHORS
Search
Search Results
##search.searchResults.foundPlural##
-
24 | IXEKIZUMAB WITH OR WITHOUT TIRZEPATIDE IN ADULTS WITH PSORIASIS AND OVERWEIGHT OR OBESITY: THE TOGETHER-PSO PHASE 3B RANDOMIZED CLINICAL TRIAL E. Filippi1, M. Lebwohl2, A. Blauvelt3, C. Kartman4, C. Leatherwood4, K. Gordon5, N. Sattar6, L. Puig7, J. Merola8, K. Siu4, R. Wang4, L. Sun4, A. Leung9, N. Somani4, M. Rueda4, A. Cardoso4, M. Genovese4, A. Armstrong10, B. Strober11 | 1Eli Lilly Italy S.p.A, Sesto Fiorentino, Italy; 2Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; 3Blauvelt Consulting, LLC, Annapolis, MD, USA; 4Eli Lilly and Company, Indianapolis, IN, USA; 5Department of Dermatology, Medical College of Wisconsin, Milwaukee, WI, USA; 6School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK; 7Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona School of Medicine, Barcelona, Spain; 8Department of Dermatology and Department of Medicine, Division of Rheumatology, UT Southwestern Medical Center and O’Donnell School of Public Health, Dallas, TX, USA; 9Syneos Health, Morrisville, NC, USA; 10Division of Dermatology, University of California Los Angeles David Geffen School of Medicine, Los Angeles, CA, USA; 11Department of Dermatology, Yale University School of Medicine, New Haven, CT, Central Connecticut Dermatology Research, Cromwell, CT, USA
119PDF: 42 -
Tight junctions in Hailey-Hailey and Darier’s diseases
1695PDF: 691HTML: 1737 -
31 | DRUG ECONOMIC ANALYSIS OF THE DOSE SPACING OF BIOLOGICAL DRUGS IN ATOPIC DERMATITIS AND PSORIASIS A. Filoni1, L. Pietroleonardo1, P. Stasi2, M. Spagnolo2, F. Scicchitano2, S. Pelle3, M. Congedo1 | 1UOSVD Dermatology and Allergology, Hospital Vito Fazzi, Lecce, Italy; 2Servizio Farmaceutico Distrettuale. Asl Lecce, Italy; 3Dermatology Outpatient Unit, Asl Lecce, Italy
95PDF: 37 -
The top 100 most cited articles in acne vulgaris: a bibliometric analysis
3366PDF: 616SUPPLEMENTARY MATERIAL: 204HTML: 26 -
Oral warty dyskeratoma: An unusual presentation
1316PDF: 604HTML: 287 -
Epidermolysis bullosa acquisita: current diagnosis and therapy
1663PDF: 929HTML: 133 -
The humanistic burden of atopic dermatitis in Greece: a cross-sectional study
930PDF: 463SUPPLEMENTARY MATERIAL: 59HTML: 18 -
Autoinflammatory diseases: what is behind them and what is new?
1899PDF: 594HTML: 166 -
25 | EARLY AND MAINTAINED TREAT-TO-TARGET RESPONSE WITH IXEKIZUMAB UP TO 5 YEARS IN MODERATE-TO-SEVERE PSORIASIS: A POST-HOC ANALYSIS OF UNCOVER-3 E. Filippi1, A. Armstrong2, J. F. Merola3, M. Megna4, X. Man5, M. Honma6, J-M. Carrascosa7, R. Chughtai7, K. Fotiou8, S. Sabatino8, M. Ngantcha8, A. Pinter9 | 1Eli Lilly Italia S.p.A, Florence, Italy; 2University of California, Los Angeles, CA, USA; 3University of Texas Southwestern Medical Center, Dallas, TX, USA; 4University of Naples Federico II, Naples, Italy; 5Zhejiang University, Hangzhou, China; 6Asahikawa Medical University, Asahikawa, Japan; 7Hospital Germans Trias, Universitat Autònoma de Barcelona, Barcelona, Spain; 8Eli Lilly and Company, Indianapolis, IN, USA; 9University Hospital Frankfurt, Frankfurt, Germany
111PDF: 26 -

